Shegoi
- Larrea, herbal remedies, healing Herpes, Lupus
- Epstein-Barr, Alzheimer’s disease,
Multiple sclerosis, Kaposi’s sarcoma,
Heart disease, Lymphomas, cancers, Bell’s
palsy
|
Shegoi home page | diseases
| safety | patents
| testimonials
|
| Order Larrea -
Shegoi |
|
Shegoi
- Larrea: The Sacred Medicinal Plant
of the Native Americans
Effective against all known viruses and disease
causing micro-organisms
* Backed by 4 United States Patents
* Field tested for six years with over
3,500 customers
* Over 90% success in clinical trials
- 100% safe - toxin free |
Note: Larreacorp was granted priority status for their patent applications based on documented utility using
Larrea-derived products to control secondary infections, caused by herpes viruses, in volunteer patients with full-blown AIDS.
Herpes Viruses
U.S. Patent 5,837,252 - Issued 17 November 1998 to
Larreacorp, Ltd.
Explanation Broad patent coverage of a method of treating herpes lesions and herpes viruses in humans using an effective amount of an extract of Larrea
tridentata.
U.S. Patent U.S. Patent 5,945,106 - Issued 31 August 1999 to
Larreacorp, Ltd.
Explanation Broad patent coverage for a method of treating herpes viruses and symptomatic herpes virus lesions of the group: herpes simplex 1 (cold sores), herpes simplex 2 (genital herpes),
varicella-zoster virus (chickenpox, shingles and post-herpetic neuralgia), human herpes virus 4 (Epstein-Barr virus, mononucleosis), human herpes virus 5 (cytomegalovirus), human herpes viruses 6 and 7
(roseoloviruses), and herpes virus 8 (Kaposi’s sarcoma).
U.S. Patent U.S. Patent 6,004,559 - Issued 21 December 1999 to
Larreacorp, Ltd.
Explanation Covers formulations containing Larrea tridentata as a herpes treatment agent.
Inflammatory Diseases
U.S. Patent 6,039,955 - Issued 21 March 2000 to
Larreacorp, Ltd.
Explanation Involves treatment of inflammation and inflammatory disease. Specifically includes: asthma, psoriases, allergic rhinitis, rheumatoid arthritis, inflammatory bowel disease, inflammatory pain, cystic fibrosis, adult respiratory distress syndrome,
glomerulonephritis, inflammation of the skin, virally induced inflammation and inflammation induced by any of contact allergens, ultraviolet light, and thermal exposure.
Diabetes
U.S. Patent 5,827,898 - Issued 27 October 1998 to Shaman Pharmaceutical Company
Explanation Involves methods for treatment of non-insulin-dependent diabetes mellitus, for reducing blood glucose levels, or hyperglycemia using compounds extracted from Larrea
tridentata.
| Shegoi
home page | diseases | safety
| patents | testimonials
|
| Order Larrea - Shegoi |
|
